Skip to main content
Log in

Leukocytoclastic vasculitis due to duloxetine

  • Correspondence
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Preskorn SH. Duloxetine. J Psychiatr Pract 2004; 10: 375–85.

    Article  PubMed  Google Scholar 

  2. Gross CM, Klöcker M, Jakob T, Klecha D. Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors. Nervenarzt 2008; 79: 1307–9.

    Article  Google Scholar 

  3. Vey EL, Kovelman I. Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey. J Forensic Leg Med 2010; 17: 175–85.

    Article  PubMed  Google Scholar 

  4. Mallinckrodt CH, Prakash A, Andorn AC. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. J Psychiatr Res 2006; 40: 337–48.

    Article  PubMed  Google Scholar 

  5. Strawn JR, Whitsel R, Nandagopal JJ, Delbello MP. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine. J Child Adolesc Physchopharmacol 2011; 21: 91–2.

    Article  Google Scholar 

  6. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 40: 111–8.

    CAS  Google Scholar 

  7. Arimone Y, Bidault I, Dutertre J-P. Update of the French drug reaction assessment method. Therapie 2011; 66: 517–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gamze Erfan.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erfan, G., Alp, R., Albayrak, S. et al. Leukocytoclastic vasculitis due to duloxetine. Eur J Dermatol 25, 194–195 (2015). https://doi.org/10.1684/ejd.2014.2491

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2014.2491

Keywords

Navigation